SMEs and investors invited to help shape the future of UK MedTech
Coming soon… the UK’s first Oligonucleotide Manufacturing Centre of Excellence: Be the first to know about our new GMP oligonucleotide manufacturing innovation capability
Digital and automation technologies to drive advanced process innovation
Method development for characterisation of AAV
Improving Patient Flow and Discharge Through Digital Innovations
Intracellular drug delivery — High throughput lipid screening and Integrating Adaptive Design of Experiments
From DNA to GMP: UKRNA service now fully open
MedTech Accelerator Rapid Regulatory Support (MARRS) Programme